Skip to content

Global Initiative
Against HPV and
Cervical Cancer

GIAHC and partners join the advocacy effort to implement the updated WHO guidelines on cervical cancer screening and treatment.

The recent release of the updated WHO guidelines on cervical cancer screening and treatment represent the beginning of a transition toward a more effective global effort to eliminate this preventable disease by emphasizing HPV testing as the preferred method of screening. GIAHC and partners agree that funders of cervical cancer prevention programs in low-resource settings must begin to communicate when and how their funding policies will prioritize the shift to HPV testing in order to facilitate this important transition at the country level. On these lines of advocacy effort, letters were sent to leadership at PEPFAR, USAID, and the Global Fund acknowledging their guidance in the creation of the new guidelines and calling for clear timelines in which to implement HPV testing in their own funding portfolios. Click here to read the letters.

More News

2024 Us vs HPV Webinar Series

The 2024 Us vs HPV webinar series will take place from January 22-26. The webinars are intended for health care providers, parents, patients, community leaders, women’s health advocates, students, young leaders and the general public. People of all genders can benefit from these talks. A live panel discussion will be hosted at the end of each session to answer audience questions.

Read More »
September 18, 2023

GIAHC looks forward to seeing its colleagues at IPVC 2023

The 35th International Papillomavirus Conference & Basic, Clinical and Public Health Scientific Workshops, will once again gather researchers, clinicians and other health professionals to share knowledge and ideas on papillomaviruses and their associated diseases, from basic science to global health impact.

Read More »
April 6, 2023